NCBiotech Directory


Issue link:

Contents of this Issue


Page 16 of 39

EG Gilero (Asheboro) provides contract design, development, manufacturing and commercialization for medical devices and drug delivery devices. The Asheboro site is a manufacturing facility. Ei, A Pharmaceutical SolutionWorks (Kannapolis) develops and manufactures liquid, semisolid and powder prescription and nonprescription skin-care and animal- health products. Eisai Inc. (Research Triangle Park) discovers, develops and markets pharmaceuticals in three main therapeutic areas: neurology, gastrointestinal disorders and oncology- critical care. Eisai's RTP facility does pharmaceutical production and formulation R&D. EMSL Analytical Inc. (Morrisville, Charlotte and Kernersville) provides analytical services, including microbiology, asbestos, indoor air quality and food testing. EN-CAS Analytical Laboratories (Winston- Salem) provides GLP-compliant analytical chemistry contract services for agrochemical, veterinary and bioanalytical research. EN-CAS has experience with preclinical and clinical trials support, pesticides, herbicides and veterinary drugs. ENCO Pharmaceutical Development Inc. (Cary) provides comprehensive product development services to the pharmaceutical and medical device market. Endacea Diagnostics Inc. (Research Triangle Park) is developing an HTRF assay to measure endotoxin (lipopolysaccharide, LPS) in both nonbiological and biological samples. Endacea Inc. (Research Triangle Park) develops A1 adenosine receptor antagonists as drug candidates for renal impairment and inf ammation, including sepsis and asthma. e-Nicotine Technology (Chapel Hill) is developing a product to combine clean nicotine aerosols for inhalation with e-health tools to help individuals transition from smoking. EnSolve Biosystems Inc. (Raleigh) produces proprietary biologically-based treatment systems to address oily bilge water, "frack" water, process waste streams and scrubber water. They also manufacture bioenzymatic degreasers/ detergents and oil-spill cleanup products. Entegrion Inc. (Research Triangle Park) develops biologic and medical device technologies to enhance the safety and availability of the human blood supply. The company also provides blood supply-related contract R&D services to the U.S. Department of Defense. Joel Stitzel, PhD, partners with industry to study injury biomechanics, computational body modeling and automotive safety. He is one of more than 1,100 faculty at Wake Forest engaged in breakthrough discoveries in basic science and clinical care. Visit to discover opportunities for broad-based partnerships with Wake Forest in the development of new therapeutics, vaccines, diagnostics and medical devices. D I S C O V E R O P E N I N N O V AT I O N AT W A K E F O R E S T Companies Fs– Ge

Articles in this issue

Links on this page

Archives of this issue

view archives of NCBiotech Directory - 2015